力成药业

Creating a centenary Leecan Guarding the health of humans

Leader in the field of advanced, complicated and innovative preparations

Creating a centenary Leecan Guarding the health of humans

Leecan Pharmaceutical is a modern and innovative pharmaceutical enterprise with integrated R&D, manufacturing, and sales, focusing on medicines for respiratory diseases, psychiatric diseases, autoimmune diseases, and common chronic diseases, etc. Leecan Pharmaceutical has already possessed R&D and production platforms for inhalation suspensions, inhalation powders and mists, inhalation aerosols, sustained and controlled release formulations, complicated injections, and improved/innovative preparations, with a fast advancement of new product projects and a high efficiency in the conversion of production.

15

+

GMP production line

40

+

Varieties in development

35

+

millions

Planned output

Leader in the field of advanced, complicated and innovative preparations

Listed product

Registration pending

New drugs in development

Compound lpratropium Bromide Solution for Inhalation

Used to treat reversible bronchospasm related to airway obstructive diseases.

Terbutaline Sulfate Nebuliser Solution

This product is indicated for the treatment of chronic bronchospasm that has failed to respond to conventional treatments and for the treatment of severe acute asthma attacks.

Budesonide Suspension for Inhalation

Treatment of bronchial asthma as an alternative to or reduction of oral steroid therapy.

Salbutamol Sulfate Inhalation Solution

It is used in the treatment of chronic bronchospasm that has failed to respond to conventional treatments and in the treatment of severe acute asthma attacks.

Fumarate Fumatrol Inhalation Solution

This product is suitable for maintenance treatment of bronchial stenosis in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, twice daily (morning and evening), and can be used for a long time.

Bendamustine Hydrochloride for Injection

Suitable for inert B-cell therapy during or after treatment with rituximab or rituximab containing regimens for disease progression Non Hodgkin's lymphoma (NHL).

Drugs

In research

Register

Approved

Ipratropium bromide solution for inhalation 2ml:0.25mg

Ipratropium bromide solution for inhalation 2ml:0.5mg

Budesonide suspension for inhalation 2ml:0.5mg

Nebulized inhalation solution of terbutaline sulfate 1ml:2.5mg

Drugs

Treatment field

In research

Register

Approved

NLDP0109

eczema

NLDP0111

COPD

HLDP0112

dispel phlegm (TCM)

LDP0202

COPD

HLDP0301

COPD

HLDP0303

eczema

HLDP0302

eczema

HLDP0503

antitumour

HLDP0504

antitumour

HLDP0505

antitumour

HLDP0506

analgesic

HLDP0507

antitumour

HLDP0508

antitumour

HLDP0509

antitumour

HLDP0510

antitumour

HLDP0603

psychiatric

HLDP0604

chronic inflammation

HLDP0607

psychiatric

HLDP0613

immune disease

Integrity, Pragmatism, Innovation, Endeavour

R&D platform

Build a top R&D team with original R&D and clinical translation capabilities for advanced complicated formulations.

Production base

High quality, maximum quantity of production with minimum input.

Quality management

Through the strict quality management system, we produce safe, high-quality, and efficient drugs that can be trusted by patients, regulators, society, and ourselves.

Pay attention to leecan leading innovation

Fumarate Fumatrol Inhalation Solution Obtained Drug Production Approval!

Two specifications of bendamustine hydrochloride for injection have obtained drug production approval!

Obtaining drug production approval for inhalation of compound ipratropium bromide solution!

Fill every minute of every patient's life
with dignity and love!

025-58181716

Friendship link：

Baidu

Website Map | Privacy Policy | Legal Notice |

© Copyright 2021 南京力成药业有限公司版权所有 All Rights Reserved.

苏ICP备2024114006号